Favourites   Have ideas?  Sign in / Register

Positive:   Immunology ↓3.52   Biopharma 0.00   Country: China 0.00 «See more»   Cancer fight ↑1.51   Disease: Oncology ↑1.51   Medicine ↑1.69

Negative:


T cell-based segment

IOVA Iovance Biotherapeutics, Inc. - Common Stock 1.15% down 8.46% -7.31 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -8.18% -8.18% 0 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
CNTB Connect Biopharma Holdings Limited - American Depositary Shares 0 + Biopharma, Country: China, T cell-based


Last highlighted: $CNTB 6-K Connect Biopharma (16 Jun, 4:01pm) 📰 Current report (foreign) https://t.co/U5Q30mPOFH #CNTB #6K #ConnectBiopharma #News
+ My List
LVTX LAVA Therapeutics N.V. - Ordinary Shares 11.56% up 10.36% 1.2 + T cell-based, Cancer fight, Medicine, Disease: Oncology

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.